ESTETRA SPRL
Estetra SPRL manufactures oral and emergency contraception products. Estetra SPRL operates as a subsidiary of Mithra Pharmaceuticals.
ESTETRA SPRL
Industry:
Manufacturing Pharmaceutical
Founded:
2009-01-01
Address:
Hollogne, Luxembourg, Belgium
Country:
Belgium
Total Employee:
11+
Status:
Active
Similar Organizations
BIOTAY SA
BIOTAY SA manufactures animal health and nutritional products.
Officina Profumo Farmaceutica di Santa Maria Novella
Santa Maria Novella's Officina Profumo Farmaceutica offers exquisite perfumes and skincare items produced with medical plants.
Sir Richard’s Condom Company
Sir Richard’s Condom Company manufactures and offers all-natural latex condoms online.
More informations about "Estetra SPRL" on Search Engine
Estetra SPRL - Crunchbase Company Profile & Funding
Headquarters Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Founded Date 2009. Operating Status Active. Company Type For Profit. Estetra SPRL manufactures oral and emergency contraception products. Estetra SPRL operates as a subsidiary of Mithra Pharmaceuticals.See details»
Estetra SPRL acquired by Mithra Pharmaceuticals SA - Crunchbase
Jan 1, 2015 Overview. Acquired Organization: Estetra SPRL Estetra SPRL manufactures oral and emergency contraception products. Acquiring Organization: Mithra Pharmaceuticals SA Mithra Pharmaceuticals SA specializes in the development of women's health care products. Announced Date Jan 1, 2015. Acquisition Type Acquisition. …See details»
Richter and Mithra strengthen their partnership and signed a …
Dec 23, 2020 (‘Richter’) and Estetra S.A, the wholly owned subsidiary of Mithra (Euronext Brussels: MITRA), today announced that they have extended their partnership and signed a license and supply agreement for the commercialization of Estelle ®, a novel 15 mg estetrol (E4) / 3 mg drospirenone containing combined oral contraceptive, in order to ...See details»
Richter and Mithra strengthen their partnership
Dec 23, 2020 Gedeon Richter Plc. and Estetra S.A, the wholly owned subsidiary of Mithra (Euronext Brussels: MITRA) ('Mithra') today announced that they have extended their partnership and signed a license and supply agreement for the commercialization of a novel 15 mg estetrol (E4) / 3 mg containing combined oral contraceptive, in order to include …See details»
Mithra | Transforming women’s health through innovation
May 3, 2024 Mithra | Transforming women’s health through innovation. Transforming women’s health through innovation. Who we are. Our clinical pipeline. Two complementary pipelines focused on women’s health: an innovative Estetrol-based platform and a portfolio of Complex Therapeutics. Explore. Estetrol, a unique estrogen.See details»
Lydisilka | European Medicines Agency
Mar 26, 2021 Overview. Lydisilka is a combined hormonal contraceptive. It contains the active substances drospirenone and estetrol monohydrate. How is Lydisilka used? How does Lydisilka work? What benefits of Lydisilka have been shown in studies? What are the risks associated with Lydisilka? Why is Lydisilka authorised in the EU?See details»
E4 programs | Mithra
Recognized as a new active substance, Mithra’s core asset Estetrol (E4) is a natural estrogen produced by the human fetus during pregnancy, passing into maternal blood at relatively high levels. Because of its unique mode of action and safety profile, Estetrol could represent a major breakthrough in various therapeutic fields of Women’s ...See details»
Efficacy of the 1-Year Segesterone Acetate/Ethinyl Estradiol ...
• Research support: AbbVie, Bayer Healthcare, Dare Bioscience, Estetra SPRL, Medicines 360, Merck, NIH, and NICHD Dr. Apter • Research support: WHO Dr. Merkatz • Works with Population Council, an international, non-profit research organization Drs. Darney and Bahamondes • No conflicts of interestSee details»
Estetrol combined with drospirenone: an oral contraceptive with …
ABSTRACT Objectives: This study evaluated acceptability, user satisfaction, body weight control and general well-being of estetrol (E4) combined with either drospirenone (DRSP) or levonorgestrel (LNG).See details»
Estetra SPRL: Drug pipelines, Patents, Clinical trials - Synapse
Explore Estetra SPRL with its drug pipeline, therapeutic area, technology platform, 2 clinical trials.See details»
Estetrol - Mithra Pharmaceuticals/Pantarhei Bioscience
At a glance. Originator Pantarhei Bioscience. Developer Estetra SPRL; Mithra Pharmaceuticals; Pantarhei Bioscience. Class Anti-inflammatories; Anti-ischaemics; Antimigraines; Antineoplastics; Antirheumatics; Cardiovascular therapies; Gonadal steroid hormones; Hormonal replacements; Oral contraceptives; Small molecules.See details»
Original Research ajog
Estetra SPRL, Hope Medicine, Medicines360, Merck, Myo-vant, and Sebela. These companies and organizations may have a commercial or financial interest in the results of this researchandtechnology.L.H.isontheadvisoryboardofClue Biomedical. The other authors report no conflict of interest. These potential conflicts of interest have been ...See details»
Public Health - Union Register of medicinal products
Nov 8, 2023 Estetra SRL. Last updated on 11/08/2023. Public Health. Union Register of medicinal products.See details»
Estetra SPRL - Tech Stack, Apps, Patents & Trademarks
Overview. The intellectual property of Estetra SPRL includes 17 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, Estetra SPRL has 1 registered trademark in the ' Pharmaceutical, veterinary and sanitary products ' class, according to IPqwery.See details»
A technology evaluation of Annovera: a segesterone acetate and …
May 15, 2020 OHSU has received research support from Abbvie, Bayer Healthcare, Daré, Estetra SPRL, Medicines360, Merck, and Sebela. These companies and organizations may have a commercial or financial interest in the results of this research and technology.See details»
François Fornieri: Positions, Relations and Network
The firm develops the projects Zoreline and Myring, which are therapeutic equivalents to branded products. The company is headquartered in Liege, Belgium. Part of Mithra Pharmaceuticals SA, Estetra SRL is a Belgian pharmaceutical …See details»
Drospirenone/estetrol - Mithra Pharmaceuticals - AdisInsight
Dec 7, 2023 Originator Estetra S.A. Developer Estetra SPRL; Fuji Pharmaceutical; Gedeon Richter; Libbs Farmaceutica; Lotus Pharmaceuticals; Mayne Pharma Group; Mithra Pharmaceuticals; Searchlight Pharma.See details»
Estetra SPRL - Updates, News, Events, Signals & Triggers
Estetra SPRL manufactures oral and emergency contraception products.See details»
Mithra Announces European Approval of Estelle
Investors.mithra.com • 1 20-05-2021 PRESS RELEASE Inside information / Regulated information Mithra Announces European Approval of Estelle® Liege, Belgium, 20 May 2021 –18:45 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, is very pleased to announce that the European Commission has accepted theSee details»
A Randomized Double-blind Placebo Controlled Phase 3 Trial to …
A Randomized Double-blind Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I) - AdisInsight. Home.See details»